AGX821 Sigma-AldrichSARS-CoV-2 Spike (aa 251-660) Recombinant Antigen, 533
Productos recomendados
Descripción
| Replacement Information |
|---|
| References |
|---|
| Product Information | |
|---|---|
| Format | Purified |
| Presentation | Purified protein in 20mM Citrate buffer without preservatives, pH 9.5. |
| Quality Segment | MQ100 |
| Physicochemical Information |
|---|
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Packaging Information | |
|---|---|
| Material Size | 1 mg |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade ITEM Number | |
|---|---|
| Número de referencia | GTIN |
| AGX821 | 04061842605934 |
Documentation
SARS-CoV-2 Spike (aa 251-660) Recombinant Antigen, 533 Ficha datos de seguridad (MSDS)
| Título |
|---|
SARS-CoV-2 Spike (aa 251-660) Recombinant Antigen, 533 Certificados de análisis
| Cargo | Número de lote |
|---|---|
| SARS-CoV-2 Spike (aa 251-660) Recombinant Antigen, 533 - Q3485639 | Q3485639 |


